Anisopus mannii
Anisopus mannii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Anisopus mannii is a botanical species that has gained scientific interest due to its diverse therapeutic potential. Research indicates that the plant's leaves possess significant hypoglycemic activities, making them relevant for managing Diabetes Mellitus. Various preparations, including aqueous extracts and hexane leaf extracts, have been studied to evaluate their biological efficacy. These extracts have demonstrated promising results in combating challenging pathogens such as Bacillus cereus, Enterococcus faecalis, and MRSA. Consequently, this plant represents a valuable resource in the search for natural agents to treat metabolic and infectious conditions.
- Synonyms
- Anisopus Rostrifer · Marsdenia Batesii · 5 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Anisopus mannii is a taxonomically complex species that has been associated with several different names throughout botanical history. It is recognized as having multiple synonyms, including the designations Anisopus batesii and Anisopus bicornatus. Furthermore, researchers have previously categorized this plant under the names Anisopus rostrifer and Marsdenia batesii. The historical record also links it to the synonym Marsdenia bicoronata, reflecting shifting scientific classifications. Understanding these various nomenclatural relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Anisopus mannii is a unique botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It further resides within the order Gentianales, showcasing its specific evolutionary lineage. As a member of the genus Anisopus, it displays distinct characteristics shared by its close relatives. Finally, this plant is firmly situated within the Apocynaceae family, marking its place in the diverse world of flowering plants.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Anisopus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Anisopus mannii is a plant species primarily distributed throughout the West Tropical Africa region. Its natural habitat spans several distinct countries across the African continent. Specifically, this species can be found growing in the landscapes of Ghana and the Ivory Coast. It also maintains a presence within the territories of Liberia and Nigeria. Furthermore, its documented range extends northward to include the country of Senegal.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Anisopus mannii is characterized by its distinctive shrub-like growth form. This species also exhibits an obligatory climbing habit, relying on other structures for support as it ascends.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Anisopus mannii has demonstrated significant potential in the pharmacological treatment of diabetes mellitus. Research into its aqueous extracts reveals a potent hypoglycemic effect, particularly when tested on alloxan-induced diabetic mice. In comparative studies, the plant achieved a remarkable fasting blood glucose reduction of 70.39 percent. This performance was notably effective, surpassing the benchmarks set by both glibenclamide and human insulin. Consequently, these findings validate the traditional medicinal use of the species and support its further development into novel anti-diabetic drugs.
Compounds
Conditions
Anisopus mannii demonstrates significant antimicrobial activity against several human pathogenic microorganisms. The hexane leaf extract of this plant effectively treats Bacillus cereus, showing the highest inhibition zone among the tested strains. It also exhibits strong inhibitory effects against Streptococcus pyogenes and Enterococcus faecalis. Furthermore, the plant provides treatment against Proteus vulgaris through notable inhibition. Finally, Anisopus mannii serves as an effective agent against the resistant strain MRSA.
Preparations
Anisopus mannii is prepared as aqueous extracts to investigate its phytochemistry and potent hypoglycemic activities in diabetic models. These aqueous preparations have demonstrated a significant ability to reduce fasting blood glucose, even outperforming glibenclamide and insulin in certain tests. Additionally, Anisopus mannii is prepared as hexane leaf extract to determine its specific chemical constituents and antimicrobial properties. The hexane leaf extract was analyzed via GC-MS to identify major compounds such as hexadecanoic acid, ethyl ester. This specific preparation also showed effective inhibition against various pathogenic microorganisms, including Bacillus cereus and Streptococcus pyogenes.
Parts used
Anisopus mannii contains bioactive properties that are particularly concentrated within its leaves. Researchers utilized a hexane extract of these leaves to identify a diverse array of chemical constituents through GC-MS analysis. The study revealed several major compounds, including hexadecanoic acid ethyl ester, which contribute to the plant's chemical profile. Testing demonstrated that this leaf extract possesses significant antimicrobial activity against various human pathogenic bacteria and fungi. Ultimately, these findings highlight the potential of the Anisopus mannii leaf as a valuable natural source for developing new antimicrobial agents.